Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
September 18, 2008

Crucell Obtains $2.5M from Talecris in Manufacturing Collaboration

  • Talecris Biotherapeutics is employing Crucell to produce a protein for $2.5 million. Under the terms of the exclusive, commercial license agreement, Crucell could earno roughly $30 million in milestone fees related to the protein across multiple indications. Crucell will use its PER.C6® cell line.